Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Benda

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Statistics in Medicine|January 19, 2010
Model-based approaches for time-dependent dose finding with repeated binary dataNorbert Benda
Pharmaceutical Statistics|January 4, 2020
Enrichment designs using placebo nonrespondersNorbert Benda, Britta Haenisch
Statistics in Medicine|July 6, 2007
Sperm count as a surrogate endpoint for male fertility controlNorbert Benda, Christoph Gerlinger
Statistics in Medicine|June 17, 2010
The impact of dropouts on the analysis of dose-finding studies with recurrent event dataMouna Akacha, Norbert Benda
Biometrical Journal. Biometrische Zeitschrift|October 25, 2011
Multiplicity issues in clinical trialsNorbert Benda, Ralf Bender
Journal of Biopharmaceutical Statistics|October 25, 2017
Regulatory issues with multiplicity in drug approval: Principles and controversies in a changing landscapeNorbert Benda, Andreas Brandt
Psychiatrische Praxis|October 7, 2004
[Non-cognitive symptoms of dementia -- prevalence and consequences]Johannes Wancata, Norbert Benda, Ullrich Meise
Pharmaceutical Statistics|July 5, 2019
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerationsCynthia Huber, Norbert Benda, Tim Friede
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|April 29, 2015
Psychiatric illness and length of stay in general hospitals: do case finding methods matter?Marion Freidl, Norbert Benda, Fabian Friedrich
Plos One|August 16, 2020
Effect size estimates from umbrella designs: Handling patients with a positive test result for multiple biomarkers using random or pragmatic subtrial allocationMiriam Kesselmeier, Norbert Benda, André Scherag
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Statistics in Medicine|January 19, 2010
Model-based approaches for time-dependent dose finding with repeated binary dataNorbert Benda
Pharmaceutical Statistics|January 4, 2020
Enrichment designs using placebo nonrespondersNorbert Benda, Britta Haenisch
Statistics in Medicine|July 6, 2007
Sperm count as a surrogate endpoint for male fertility controlNorbert Benda, Christoph Gerlinger
Statistics in Medicine|June 17, 2010
The impact of dropouts on the analysis of dose-finding studies with recurrent event dataMouna Akacha, Norbert Benda
Biometrical Journal. Biometrische Zeitschrift|October 25, 2011
Multiplicity issues in clinical trialsNorbert Benda, Ralf Bender
Journal of Biopharmaceutical Statistics|October 25, 2017
Regulatory issues with multiplicity in drug approval: Principles and controversies in a changing landscapeNorbert Benda, Andreas Brandt
Psychiatrische Praxis|October 7, 2004
[Non-cognitive symptoms of dementia -- prevalence and consequences]Johannes Wancata, Norbert Benda, Ullrich Meise
Pharmaceutical Statistics|July 5, 2019
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerationsCynthia Huber, Norbert Benda, Tim Friede
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|April 29, 2015
Psychiatric illness and length of stay in general hospitals: do case finding methods matter?Marion Freidl, Norbert Benda, Fabian Friedrich
Plos One|August 16, 2020
Effect size estimates from umbrella designs: Handling patients with a positive test result for multiple biomarkers using random or pragmatic subtrial allocationMiriam Kesselmeier, Norbert Benda, André Scherag
Pageof 5